Beijing SL Pharmaceutical Co Ltd (002038) — Free Cash Flow Generation Index
Beijing SL Pharmaceutical Co Ltd (002038) has a Free Cash Flow Generation Index of 0.83x as of September 2025. Free cash flow of CN¥55.21 Million represents 1% of operating cash flow (CN¥66.55 Million). Explore reinvestment intensity of Beijing SL Pharmaceutical Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Beijing SL Pharmaceutical Co Ltd Free Cash Flow Generation Index (2003–2025)
Historical FCF Generation Index trend for Beijing SL Pharmaceutical Co Ltd across 23 annual periods. For the full cash flow conversion analysis, see Beijing SL Pharmaceutical Co Ltd (002038) cash flow conversion.
Annual Free Cash Flow Generation for Beijing SL Pharmaceutical Co Ltd (2003–2025)
Year-by-year Free Cash Flow Generation Index for Beijing SL Pharmaceutical Co Ltd. Check Beijing SL Pharmaceutical Co Ltd (002038) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.25x | CN¥64.69 Million | CN¥257.66 Million | CN¥192.97 Million | ▲ +146.4% |
| 2024 | -0.54x | CN¥-121.89 Million | CN¥225.49 Million | CN¥347.38 Million | ▼ -202.9% |
| 2023 | 0.53x | CN¥241.84 Million | CN¥460.20 Million | CN¥218.36 Million | ▼ -9.5% |
| 2022 | 0.58x | CN¥226.33 Million | CN¥389.82 Million | CN¥163.49 Million | ▲ +18.5% |
| 2021 | 0.49x | CN¥227.72 Million | CN¥464.63 Million | CN¥236.91 Million | ▲ +27.5% |
| 2020 | 0.38x | CN¥159.89 Million | CN¥415.84 Million | CN¥255.95 Million | ▼ -34.9% |
| 2019 | 0.59x | CN¥393.04 Million | CN¥665.83 Million | CN¥272.78 Million | ▲ +11.1% |
| 2018 | 0.53x | CN¥257.80 Million | CN¥485.17 Million | CN¥227.37 Million | ▲ +33.9% |
| 2017 | 0.40x | CN¥151.08 Million | CN¥380.72 Million | CN¥229.65 Million | ▼ -32.3% |
| 2016 | 0.59x | CN¥232.65 Million | CN¥396.86 Million | CN¥164.21 Million | ▼ -21.1% |
| 2015 | 0.74x | CN¥375.19 Million | CN¥504.87 Million | CN¥129.68 Million | ▲ +10.1% |
| 2014 | 0.68x | CN¥313.99 Million | CN¥465.00 Million | CN¥151.01 Million | ▼ -1.4% |
| 2013 | 0.68x | CN¥237.94 Million | CN¥347.41 Million | CN¥109.48 Million | ▲ +81.1% |
| 2012 | 0.38x | CN¥150.70 Million | CN¥398.60 Million | CN¥247.89 Million | ▼ -44.4% |
| 2011 | 0.68x | CN¥155.54 Million | CN¥228.59 Million | CN¥73.05 Million | ▼ -16.9% |
| 2010 | 0.82x | CN¥195.09 Million | CN¥238.13 Million | CN¥43.04 Million | ▼ -0.7% |
| 2009 | 0.83x | CN¥143.95 Million | CN¥174.41 Million | CN¥30.46 Million | ▼ -6.0% |
| 2008 | 0.88x | CN¥170.71 Million | CN¥194.32 Million | CN¥23.61 Million | ▲ +25.7% |
| 2007 | 0.70x | CN¥61.75 Million | CN¥88.36 Million | CN¥26.61 Million | ▲ +644.0% |
| 2006 | -0.13x | CN¥-7.39 Million | CN¥57.55 Million | CN¥64.95 Million | ▲ +81.9% |
| 2005 | -0.71x | CN¥-33.76 Million | CN¥47.48 Million | CN¥81.24 Million | ▼ -264.3% |
| 2004 | 0.43x | CN¥13.53 Million | CN¥31.26 Million | CN¥17.73 Million | ▼ -6.4% |
| 2003 | 0.46x | CN¥14.12 Million | CN¥30.55 Million | CN¥16.43 Million | — |